Orthofix Medical Inc (OFIX) Inventory Turnover Ratio, from first quarter 2026 to first quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 
Orthofix Medical Inc   (NASDAQ: OFIX)
 

Orthofix Medical Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the first quarter 2026, Orthofix Medical Inc 's inventory turnover ratio sequentially decreased to 2.79 in the first quarter 2026, otherwise the ratio remained above the average, as OFIX's markets remain strong.Orthofix Medical Inc 's average inventory processing period in the Mar 31 2026 quarter, has increased to 131 days, from 125 days, in the Dec 31 2025 quarter.

Within Healthcare sector 142 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1376 in the fourth quarter 2025, to 1639.

OFIX Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Orthofix Medical Inc Market Share?

What is Inventory Turnover Ratio?




OFIX Inventory Turnover Ratio (Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
(Mar 31 2025)
I. Quarter
Y / Y Inventory Growth -4.21 % -18.18 % -24.89 % -31.16 % -30.6 %
Y / Y Cost of Sales Growth -20.64 % -5.88 % -7.22 % -0.44 % 17.37 %
Inventory Turnover Ratio (TTM) 2.79 2.92 2.82 2.65 2.42
OFIX's Total Ranking # 1639 # 1376 # 1085 # 1370 # 1137
Average inventory processing period 131 125 130 137 151
Seq. Inventory Growth 1.79 % -2.37 % 3.88 % -7.21 % -13.05 %
Seq. Cost of Sales Growth -10.68 % 12.06 % -10.19 % -11.72 % 5.92 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 59
Healthcare Sector # 143
Overall Market # 1639

Inventory Turnover Ratio Statistics
High Average Low
5.46 2.56 1.42
(Sep 30 2021)   (Mar 31 2012)




Financial Statements
Orthofix Medical Inc 's Inventories $ 88 Millions Visit OFIX's Balance sheet
Orthofix Medical Inc 's Cost of Revenues TTM $ 242 Millions Visit OFIX's Income Statement
What are OFIX's Sales? Visit OFIX's Sales by Segment

Other Inventory Turnover Ratios
Orthofix Medical Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
OFIX's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for OFIX's Competitors
Inventory Turnover Ratio for OFIX's Suppliers
Inventory Turnover Ratio for OFIX's Customers

You may also want to know
OFIX's Sales Growth Rates OFIX's Pe Price to earnings ratio OFIX's Receivables Turnover Ratio OFIX's Stock Quote
OFIX's Net Income Growth Rates OFIX's Ps Price to Sales ratio OFIX's Sales per Employee OFIX's Asset Turnover Ratio
OFIX's Net Margin OFIX's Pb Price to Book ratio OFIX's Financial Strength Ratios OFIX's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Mar 31 2026 Inventories at quarter ending Mar 31 2026
Charles River Laboratories International inc   7.56 $ 2,346.239  Millions$ 310  Millions
Adaptive Biotechnologies Corporation  7.43 $ 73.088  Millions$ 10  Millions
Puma Biotechnology Inc   7.19 $ 58.025  Millions$ 8  Millions
Fonar Corporation  7.06 $ 19.685  Millions$ 3  Millions
Carlisle Companies Incorporated  6.71 $ 3,206.100  Millions$ 478  Millions
Hims and Hers Health Inc   6.58 $ 670.000  Millions$ 102  Millions
Vanda Pharmaceuticals Inc   6.54 $ 12.682  Millions$ 2  Millions
Twist Bioscience Corporation  6.50 $ 196.251  Millions$ 30  Millions
Phathom Pharmaceuticals Inc   6.48 $ 30.871  Millions$ 5  Millions
Precision Optics Corporation Inc   6.47 $ 24.932  Millions$ 4  Millions
Nuo Therapeutics Inc   6.42 $ 1.331  Millions$ 0  Millions
Collegium Pharmaceutical Inc   6.41 $ 256.071  Millions$ 40  Millions
Veracyte Inc   6.05 $ 132.000  Millions$ 22  Millions
Kewaunee Scientific Corporation  5.98 $ 200.155  Millions$ 33  Millions
Adm Tronics Unlimited Inc   5.93 $ 1.992  Millions$ 0  Millions
Align Technology inc   5.81 $ 1,327.000  Millions$ 228  Millions
Transmedics Group Inc   5.71 $ 260.151  Millions$ 46  Millions
Opko Health Inc   5.69 $ 372.048  Millions$ 65  Millions
Avantor Inc   5.55 $ 4,447.000  Millions$ 801  Millions
Steris Plc  5.27 $ 3,309.400  Millions$ 628  Millions
Bristol myers Squibb Company  5.24 $ 14,324.000  Millions$ 2,735  Millions
Harrow Inc   5.11 $ 69.568  Millions$ 14  Millions
Integer Holdings Corporation  5.11 $ 1,365.000  Millions$ 267  Millions
Tactile Systems Technology Inc   5.08 $ 81.000  Millions$ 16  Millions
Integrated Biopharma Inc  4.96 $ 45.000  Millions$ 9  Millions
Ufp Technologies Inc   4.95 $ 436.000  Millions$ 88  Millions
Polomar Health Services, Inc.  4.79 $ 0.642  Millions$ 0  Millions
Henry Schein Inc   4.70 $ 9,209.000  Millions$ 1,959  Millions
Bionexus Gene Lab Corp   4.70 $ 4.191  Millions$ 1  Millions
Medinotec Inc   4.69 $ 4.864  Millions$ 1  Millions

Date modified: 2026-08-30T14:42:49+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.